The Organic, Nanoparticles & Biologics Synthesis Team
We are experts in organic synthesis of complex organic molecules with therapeutic potential with unique skill sets that include Bioconjugation and Biologics synthesis using micro-organisms such as bacteria and with commercial synthesizers.


Philip Adero PhD.
A goal oriented, self-motivated and performance-focused Senior Scientist, offering hands-on experience in tackling drug discovery challenges through organic synthesis, armed with proven capabilities in designing, developing and carrying out multistep synthesis; mechanistic investigations, and target oriented novel method development. Equipped with unparalleled work ethic, along with proven capabilities to handle and complete varying and increasing levels of responsibilities. Proficient in modern organic materials synthesis, purification and characterization techniques.
Key Skills: Synthetic Organic Chemistry | Chemical Process Development | Material Analysis | Technical Reporting | Mentorship | Track record of Publications | Chromatographic Skills | Mass Spectrometry | Nuclear Magnetic Resonance | Fourier Transform-Infrared | Ultraviolet–Visible Spectroscopy | Gas Chromatography–Mass Spectrometry | Liquid Chromatography–Mass Spectrometry | Medicinal chemistry | Drug development | Library synthesis | Total synthesis | Great Communication Skills | SAR techniques |Scale-ups|
Benson Edagwa PhD.
Professor at the University of Nebraska Medical Center, NSRI Fellow and Co-Founder, Exavir Therapeutics Inc.
Benson Edagwa is The Community Pride of Nebraska Endowed Professor of Pharmacology and Neuroscience at the University of Nebraska Medical Center (UNMC). He earned his undergraduate degree in 2005 from Moi University, Kenya, and a Ph.D. in Chemistry from Louisiana State University in 2012. Dr. Edagwa has played a pivotal role in the development of several new inventions that have been licensed and are being developed to treat chronic illnesses. While at UNMC, Dr. Edagwa has been listed as an inventor on 84 US patent applications. These numbers put Dr. Edagwa in the top 1% of all innovative faculty at UNMC. He also has formed significant collaborations with industry, having co-founded Exavir Therapeutics, a startup company created to develop ultra-long-acting therapies for viral infections and CNS disorders. Exavir received UNeMed’s “Startup of the Year Award” in 2022. The goal of Dr. Edagwa’s research is to transform frequently administered therapies into novel ultra-long-acting safe medicines that can be dosed once-every-sixmonths or even once-a-year to facilitate prevention and treatment of persistent illnesses such as HIV infection, viral hepatitis, tuberculosis, malaria, and addiction to opiates. His volunteer experiences in helping patients living with HIV/AIDS in Africa shaped his career goals. In addition to mentoring numerous graduate students at UNMC, Dr. Edagwa has continued to provide research mentorship opportunities to undergraduate and high school students from diverse educational and socioeconomic backgrounds across Nebraska with the goal of enhancing their interest in health sciences. His work has won numerous Awards and has continuously been supported through the National Institutes of Health, Nebraska community and global pharmaceutical companies. His collaborative work holds great promise to transform healthcare for the least fortunate.




Eman Akam-Baxter PhD.
PI at Mass General Hospital & Harvard Medical School
I am a PI at Mass General Hospital and Harvard Medical School. I'm designing small molecule and nanoparticle-based molecular imaging probes
Elizabeth Okoth PhD.
Ph.D. Organic Chemistry 2017 Louisiana State University, Baton Rouge, LA
Currently, Lecturer at University of Alabama in Huntsville.




Professor of Organic Chemistry at Montgomery College
RACHEL M. NDONYE, PhD (2006)
Associate Professor, Chemistry
BA, St. Joseph’s University
BS, University of Nairobi (Kenya)
PhD, University of Connecticut
Fidelis Ndombera PhD.
Experienced Biochemist with pharmaceutical industrial, research and teaching experience that include Drug and Bioassay development, Molecular Biology, Illumina Sequencing, NanoString Technology, Protein Chemistry, Immunochemistry, LC/MS and Cell-based Assays . Skilled in Cancer Research, Team-building, Leadership , education and training. Strong research professional with a PhD in Chemistry (Biochemistry major, Analytical Chemistry minor). Currently involved in development of Biopharm Chemistry Manufacturing controls and Drug development utilizing diverse techniques with Cell-based assays, Flow Cytometry, Immunochemistry and qPCR among others. I utilize tools such as Biacore Technology., QuantStudio, ELISA,BD FACS Lyric Flow cytometer among others. I also have developed genomic assays using cells, clinical samples that include blood, urine and FFPE human tissues with Illumina NGS and Nanostring gene expression technologies among others.